Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring method

Amit G. Pandya, Linda S. Hynan, Rafia Bhore, +9

Journal of the American Academy of Dermatology

ReliabilityMelasma AreaReliability AssessmentDiagnosisPathology +3

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

Richard G. Langley, Steven R. Feldman, Chenglong Han, +6

Journal of the American Academy of Dermatology

PsychoneuroimmunologyPsychiatrySystemic TreatmentClinical TrialsDepression +6

Glycogen Synthase Kinase 3β Is Activated by cAMP and Plays an Active Role in the Regulation of Melanogenesis

Mehdi Khaled, Lionel Larribère, Karine Bille, +4

Journal of Biological Chemistry

Microphthalmia-associated Transcription Factor Regulates RAB27A Gene Expression and Controls Melanosome Transport

C. Chiavérini, Laurent Beuret, Enrica Flori, +7

Journal of Biological Chemistry

Transcriptional RegulationMolecular PhysiologyDevelopmental BiologySignal TransductionControls Melanosome Transport +9

Inhibition of Rho Is Required for cAMP-induced Melanoma Cell Differentiation

Roser Buscà, Corine Bertolotto, Patricia Abbe, +6

Molecular Biology of the Cell

Molecular BiologyTarget P160CytoskeletonCellular PhysiologyTumor Biology +17

Characterization of the Molecular Defects in Rab27a, Caused by RAB27A Missense Mutations Found in Patients with Griscelli Syndrome

Philippe Bahadoran, Roser Buscà, C. Chiavérini, +8

Journal of Biological Chemistry

Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis.

Jean-Paul Ortonne, Mark Lebwohl, C.E.M. Griffiths

PubMed

InflammationAlefacept-induced DecreasesAutoimmune DiseaseMedicineImmunology +13

Skin and Nail Responses after 1 Year of Infliximab Therapy in Patients with Moderate-to-Severe Psoriasis: A Retrospective Analysis of the EXPRESS Trial

Kristian Reich, Jean-Paul Ortonne, Urs Kerkmann, +5

Dermatology

A novel homozygous nonsense mutation in the LAMC2 gene in patients with the Herlitz junctional epidermolysis bullosa

C. Baudoin, Corinne Miquel, G Laurent, +6

Human Molecular Genetics

Skin DevelopmentMolecular Diagnostic TechniquesMendelian DisorderItaly SearchMedicine +13

Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis.

Jean-Paul Ortonne, Jörg C. Prinz

PubMed

ImmunologyBiological TherapyPharmacotherapyDermatologyImmunotherapy +15